Peanut Oral Immunotherapy in Children With Peanut Allergy (Peanut Flour)

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 11, 2020

Study Completion Date

February 11, 2020

Conditions
Peanut Allergic Subjects
Interventions
BIOLOGICAL

Peanut Oral Immunotherapy (POIT)

The peanut protein is ingested in the form of peanut flour. Peanut flour will be given in small pre-measured soufflé cups containing the amount of peanut flour that needs to be eaten for one dose. One dose will be taken per day. Dosage of the peanut flour will begin with 1.8 mg of peanut protein during the initial visit or the lowest tolerated dose on initial challenge and increased every 2 during the build-up phase until the maintenance dose of peanut protein (3900 mg) is reached.

Trial Locations (1)

77030

Texas Children's Hospital, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT02203799 - Peanut Oral Immunotherapy in Children With Peanut Allergy (Peanut Flour) | Biotech Hunter | Biotech Hunter